Jo Viney

Jo Viney is an experienced biotech executive and entrepreneurial scientist who has taken 13 drugs to clinic.

Dr Viney is Founder, President and CEO of Seismic Therapeutic, the machine learning immunology company. Prior to founding Seismic, she founded Pandion Therapeutics in 2017 and served as President and CSO until the acquisition by Merck for $1.85B in 2021. Prior to founding Pandion, she worked at Biogen, Amgen, and Immunex.

Jo is an independent board director for Finch Therapeutics, Harpoon Therapeutics, Graphite Bio and Lab Central, and is an advisory board member for HotSpot Therapeutics. Jo was featured in Endpoints’ 2019 Special Report on 20 Extraordinary Women, and in FiercePharma’s 2020 Fiercest Women in Life Sciences.

Jo is an advocate for workplace inclusiveness. She has served on the board of WEST, a non-profit organization supporting early to mid-career women, including as President 2017-18.